Ben van der Schaaf is a Cutter Consortium Senior Consultant and a Partner at Arthur D. Little (ADL), based in New York City. He is an experienced management consultant and advisor to the pharmaceutical industry with an international background in finance and general management. Mr. van der Schaaf focuses on the life sciences and healthcare sector, specifically working in pharmaceutical R&D and commercial operations. His expertise includes post-merger integration, complex program delivery, quality and compliance, strategic sourcing and partnering, organizational analysis and design, commercialization, salesforce effectiveness, and operations management. Mr. van der Schaaf is skilled in stakeholder management, change management, and collaboration and has strong analytical and financial management skills. In addition, he has broad international business experience. Mr. van der Schaaf  earned an undergraduate degree in accounting and auditing from NIVRA-Nyenrode, the Netherlands, and an MBA with an operations and finance concentration from Maine Business School of the University of Maine. In addition, he has studied business design and business and enterprise architecture at Henley Management College. He can be reached at experts@cutter.com.